<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01448798</url>
  </required_header>
  <id_info>
    <org_study_id>AnPro</org_study_id>
    <nct_id>NCT01448798</nct_id>
  </id_info>
  <brief_title>Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.</brief_title>
  <acronym>AnPro</acronym>
  <official_title>Prospective Randomized Investigation of Athermal Nerve-sparing During Robotic-assisted Laparoscopic Prostatectomy Using a Hemostatic Gelatin-thrombin Matrix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix
      during athermal nerve-sparing prostate resection compared to conventional hemostasis using
      electrocautery in patients with localized prostate cancer and to investigate effects on
      postoperative erectile function and continence.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative erectile function</measure>
    <time_frame>12 months</time_frame>
    <description>Postoperative erectile function compared to preoperative status assessed validated questionnaires.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative continence</measure>
    <time_frame>12 months</time_frame>
    <description>Postoperative continence compared to preoperative status assessed by validated questionnaires.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative bloodloss</measure>
    <time_frame>During surgery</time_frame>
    <description>Amount of blood collected in the suction during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra- and postoperative complications</measure>
    <time_frame>Perioperative period</time_frame>
    <description>Intra- and postoperative complications associated to the studyÂ´s intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>gelatine-thrombin matrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nerves-paring during robotic-assisted laparoscopic prostatectomy is conducted without mono- or bipolar electrocautery and clipping by using a hemostatic gelatine-thrombin matrix.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Nerve-sparing during robotic-assisted radical prostatectomy is conducted with the use of mono- and bipolar electrocautery and surgical clipping.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Application of a hemostatic gelatin-thrombin matrix</intervention_name>
    <description>Hemostatic gelatin-thrombin matrix is used for hemostasis during nerve-sparing dissection of the prostate.</description>
    <arm_group_label>gelatine-thrombin matrix</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Use of mono- and bipolar electrocautery and surgical clips</intervention_name>
    <description>Mono- and bipolar electrocautery and surgical clips are used for hemostasis during nerve-sparing dissection of the prostate.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age &gt;18

          -  Histologically proven prostate cancer ( Gleason &lt;8; PSA&lt;10ng/ml)

          -  Disease confined to prostate in clinical examination

          -  Preoperative IEEF-5-Score&gt;20

          -  Patient is able to give informed consent

        Exclusion Criteria:

          -  ASA IV-V

          -  Prior extensive abdominal surgery

          -  Signs for metastatic disease

          -  Known allergy against bovine material

          -  Patient is unable to give informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Haferkamp, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johann Wolfgang Goethe University Hospitals, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Axel Haferkamp, Prof.</last_name>
    <phone>+49-69-6301-5352</phone>
    <email>axel.haferkamp@kgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael A Reiter, Dr.</last_name>
    <phone>+49-69-6301-5352</phone>
    <email>michael.reiter@kgu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University Hospital</name>
      <address>
        <city>Frankfurt/M.</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Haferkamp, Prof.</last_name>
      <phone>+49-69-6301-5352</phone>
      <email>axel.haferkamp@kgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael A Reiter, Dr.</last_name>
      <phone>+49-69-6301-5352</phone>
      <email>michae.reiter@kgu.de</email>
    </contact_backup>
    <investigator>
      <last_name>Michael A Reiter, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Haferkamp, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2011</study_first_submitted>
  <study_first_submitted_qc>October 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2011</study_first_posted>
  <last_update_submitted>October 6, 2011</last_update_submitted>
  <last_update_submitted_qc>October 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Axel Haferkamp</investigator_full_name>
    <investigator_title>Prof. Dr. med. Axel Haferkamp</investigator_title>
  </responsible_party>
  <keyword>radical prostatectomy</keyword>
  <keyword>robotic surgery</keyword>
  <keyword>erectile dysfunction</keyword>
  <keyword>continence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Thrombin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

